Stock Research

Is there any upside left in DAWN stock as it soars 65%?

Day One Biopharmaceuticals (NASDAQ: DAWN) ripped higher on Friday morning after Servier signed a definitive agreement to acquire the California-based firm for about $2.5 billion in cash.Servier’s deal rewrites DAWN’s...

CHECK STOCK PERFORMANCE

MARKET INFORMATION

  • LAST
    CHANGE
  • S&P 500
    6738.15
    -92.56 (-1.36)
  • DJI
    47501.54
    -453.21 (-0.95)
  • NASDAQ
    22387.68
    -361.31 (-1.59)
  • OIL
    28.42
    +0.27 (+0.96)

Today's Top Gainers

  • Stock
    Price Change
  • GECCI
    223.95%
  • PRSO
    151.54%
  • DXST
    83.61%
  • EDSA
    80.61%
  • CRE
    72.90%
  • ANTX
    66.67%
  • DAWN
    65.88%
  • EPSM
    64.15%
  • SYNX
    57.99%
  • SEV
    38.98%

Today's Top Losers

  • Stock
    Price Change
  • CLDI
    -53.14%
  • MDCX
    -42.87%
  • CCHH
    -39.46%
  • OWLT
    -38.21%
  • SKYQ
    -37.74%
  • LNAI
    -35.77%
  • PMAX
    -33.87%
  • CELG-RI
    -31.84%
  • BEG
    -30.18%
  • PROF
    -29.11%